Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$514M |
| 2 |
AGN
Allergan plc
AGN
|
+$364M |
| 3 |
Medtronic
MDT
|
+$323M |
| 4 |
Gilead Sciences
GILD
|
+$299M |
| 5 |
TripAdvisor
TRIP
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.01B |
| 2 |
AGN
Allergan Inc
AGN
|
+$795M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$525M |
| 4 |
Apple
AAPL
|
+$473M |
| 5 |
Microsoft
MSFT
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.07% |
| 2 | Healthcare | 14.43% |
| 3 | Financials | 13.22% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Discretionary | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
I
3001
DELISTED
INTELSAT S. A.
I
| $1.49M | ﹤0.01% |
124,311
-6,653
| -5% | -$95.6K |
|
3002
Covenant Logistics
CVLG
$865M
| $1.48M | ﹤0.01% |
89,100
+16,076
| +22% | +$244K |
|
3003
LGI Homes
LGIH
$1.32B
| $1.48M | ﹤0.01% |
88,629
+8,078
| +10% | +$113K |
|
3004
WisdomTree International MidCap Dividend Fund
DIM
$169M
| $1.47M | ﹤0.01% |
24,973
+16,895
| +209% | +$978K |
|
|
ECYT
3005
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $1.47M | ﹤0.01% |
234,646
+17,637
| +8% | +$102K |
|
3006
Utah Medical Products
UTMD
$230M
| $1.47M | ﹤0.01% |
24,478
+413
| +2% | +$24.3K |
|
|
SFY
3007
DELISTED
SWIFT ENERGY CO (HOLDING COMPANY)
SFY
| $1.46M | ﹤0.01% |
677,503
-146,001
| -18% | -$379K |
|
3008
Extreme Networks
EXTR
$3.16B
| $1.46M | ﹤0.01% |
461,393
+12,176
| +3% | +$39.7K |
|
|
TARO
3009
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.46M | ﹤0.01% |
10,346
+1,916
| +23% | +$295K |
|
|
EIGR
3010
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.46M | ﹤0.01% |
171
+37
| +28% | +$323K |
|
3011
LSI Industries
LYTS
$890M
| $1.45M | ﹤0.01% |
178,354
-1,886
| -1% | -$13.9K |
|
|
EPZM
3012
DELISTED
Epizyme, Inc
EPZM
| $1.45M | ﹤0.01% |
77,400
+20,734
| +37% | +$428K |
|
|
BV
3013
DELISTED
Bazaarvoice, Inc.
BV
| $1.45M | ﹤0.01% |
256,729
+5,644
| +2% | +$43.4K |
|
3014
Descartes Systems
DSGX
$6.62B
| $1.45M | ﹤0.01% |
96,154
+11,571
| +14% | +$175K |
|
3015
eHealth
EHTH
$38.8M
| $1.45M | ﹤0.01% |
154,275
-12,425
| -7% | -$148K |
|
|
OHAI
3016
DELISTED
OHA Investment Corporation
OHAI
| $1.45M | ﹤0.01% |
274,540
-10,000
| -4% | -$48.3K |
|
3017
STRATTEC Security
STRT
$338M
| $1.44M | ﹤0.01% |
19,566
+332
| +2% | +$23.6K |
|
|
HILL
3018
DELISTED
DOT HILL SYSTEMS CORP
HILL
| $1.44M | ﹤0.01% |
271,706
-385
| -0.1% | -$1.77K |
|
3019
NMI Holdings
NMIH
$3.38B
| $1.44M | ﹤0.01% |
192,193
| – | – |
|
|
LBMH
3020
DELISTED
LIBERATOR MED HLDGS INC (NY)
LBMH
| $1.43M | ﹤0.01% |
408,640
+35,058
| +9% | +$120K |
|
|
OMED
3021
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $1.43M | ﹤0.01% |
55,360
-9,751
| -15% | -$247K |
|
|
MRGE
3022
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
| $1.42M | ﹤0.01% |
318,473
-19,899
| -6% | -$83.1K |
|
|
NMBL
3023
DELISTED
Nimble Storage, Inc.
NMBL
| $1.41M | ﹤0.01% |
63,022
-120
| -0.2% | -$2.92K |
|
3024
WisdomTree True Developed International Fund
DOL
$848M
| $1.41M | ﹤0.01% |
28,844
+4,100
| +17% | +$198K |
|
3025
Lexicon Pharmaceuticals
LXRX
$1.04B
| $1.4M | ﹤0.01% |
212,246
+24,142
| +13% | +$165K |
|
Similar funds
Bank of New York Mellon's Q1 2015 Portfolio in Review
As of Q1 2015, Bank of New York Mellon held 4,377 positions worth $385B, up 0.54% from $383B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bank of New York Mellon's Q1 2015 filing shows 128 new, 2,179 increased, 1,685 reduced and 142 closed positions. Its largest new stake was Qorvo: 1,775,142 shares worth $141M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.01B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q1 2015 buy was Qorvo: 1,775,142 shares worth $141M.
- Bank of New York Mellon added most to Cognizant in Q1 2015, an estimated $514M increase.
- Bank of New York Mellon's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.01B.
- Bank of New York Mellon fully exited Allergan Inc in Q1 2015, selling an estimated $795M.
- Bank of New York Mellon's ten largest holdings make up 13% of its $385B portfolio in Q1 2015.
- Bank of New York Mellon opened 128 new positions and closed 142 in Q1 2015.
- Bank of New York Mellon's portfolio value rose 0.54% quarter-over-quarter to $385B.
Based on Bank of New York Mellon's 13F filing for Q1 2015, filed 13 May 2015.